Controlling ischemic cardiovascular disease: from basic mechanisms to clinical management

Area of Science:

• Cardiovascular Medicine
• Molecular Cardiology
• Genetics

Background:

• Cardiovascular disease (CVD) understanding is rapidly advancing.
• New molecular techniques, protein function models, and population genetics enhance disease analysis.
• Coronary stenosis and myocardial dysfunction are key areas of focus.

Purpose of the Study:

• To review current prevention and therapy strategies for coronary stenosis.
• To discuss management of acute and chronic coronary flow impairment and myocardial damage.
• To explore the role of population genetics and genetic therapeutics in ischemic CVD.

Main Methods:

• Review of molecular, genetic, and population-based approaches.
• Discussion of pharmacologic and mechanical interventions for coronary stenosis.
• Analysis of treatments for myocardial damage, heart failure, and arrhythmias.

Main Results:

• Coronary stenosis therapies include mechanical dilation, stenting (drug-eluting and bare-metal), and bypass surgery.
• Management of myocardial damage and pump failure are critical for cardiac function.
• Population genetics offers potential for personalized genetic therapeutic guidance.

Conclusions:

• Integrated approaches combining molecular, genetic, and clinical strategies are crucial for CVD management.
• Advancements in revascularization techniques significantly impact patient outcomes.
• Genetic insights hold promise for future therapeutic interventions in ischemic heart disease.